Loading clinical trials...
Loading clinical trials...
The objective of the present study is to describe the negative impact on oral and gut microbiota of a severe acute respiratory syndrome SARS-CoV-2 infection in patients hospitalized in intensive care ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University Hospital, Toulouse
NCT05181696 · COVID-19 Pneumonia, Sepsis, and more
NCT05142553 · COVID-19, SARS-CoV-2 Acute Respiratory Disease
NCT05004181 · SARS-CoV-2 Infection, COVID-19, and more
NCT05097677 · COVID-19 Pneumonia, COVID-19 Respiratory Infection, and more
NCT04896866 · Covid19, COVID-19 Pneumonia, and more
University Hospital of Toulouse
Toulouse
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions